Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cancers|January 11, 2025
Synergistic Potential of Antibiotics with Cancer TreatmentsGiuseppe Nardo, Pan Pantziarka, Matteo Conti
Frontiers in Pharmacology|April 12, 2019
A Computational Model of Tumor Growth and AnakoinosisPan Pantziarka, Lina Ghibelli, Albrecht Reichle
European Journal of Cancer (Oxford, England : 1990)|April 23, 2021
The European Union and personalised cancer medicineJohn A Hickman, Ian F Tannock, Lydie Meheus, et al.
Personalized Medicine|May 23, 2018
GENimmune NVGeert Maertens, Lydie Meheus, Fred Shapiro, et al.
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
Ecancermedicalscience|November 12, 2015
The wisdom of crowds and the repurposing of artesunate as an anticancer drugYolanda Augustin, Sanjeev Krishna, Devinder Kumar, et al.
Ecancermedicalscience|July 31, 2020
Repurposing of drugs for triple negative breast cancer: an overviewAndrea Spini, Sandra Donnini, Pan Pantziarka, et al.
Ecancermedicalscience|July 24, 2018
Propranolol and breast cancer-a work in progressPan Pantziarka, Brad A Bryan, Sergio Crispino, et al.
Hematology/Oncology Clinics of North America|May 14, 2025
Approaches to Ultra-Rare Sarcomas: Definitions, Diagnostics, and TherapiesAlessandra Merlini, Angelo Paolo Dei Tos, Pan Pantziarka, et al.
Oncoimmunology|March 5, 2016
Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancerDinesh Chandra, Arthee Jahangir, Francois Cornelis, et al.
Pageof 6